City

Hong Kong (1)

Tianjin (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Institute of Hematology & Blood Diseases Hospital (1)

The University of Hong Kong (1)

Collaborator

Janssen, LP (1)

Intervention

allogeneic hematopoietic stem cell transplantation (1)

autologous hematopoietic stem cell transplantation x 1 or x 2 (1)

decitabine (1)

fludarabine injection (1)

melphalan given iv (1)

pi and dexamethasone as maintenance therapy (1)

pi+imids+dexamethasone as consolidated chemotherapy (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

complex karyotype

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, Complex Karyotype Trial in Hong Kong (Decitabine)

Recruiting

Acute Myeloid Leukemia
Complex Karyotype

Decitabine

Hong Kong, Hong Kong

The University of Hong Kong

Apr 26, 2021

Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Plasmacytoma Trial in Tianjin (Allogeneic Hematopoietic Stem Cell

Unknown status

Multiple Myeloma
+8 more

Allogeneic Hematopoietic Stem Cell Transplantation
+5 more

Tianjin, Tianjin, China

Institute of Hematology and Blood Diseases Hospital Chinese Acad

Jul 3, 2019